Advertisement
Person › Details
Thierry Bernard (Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA))
Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations)
Organisation | Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) | |
Group | Qiagen (Group) | |
Former/major organisation | bioMérieux S.A. (Euronext: BIM) | |
Group | Mérieux (Group) | |
Product | molecular diagnostics | |
Product 2 | in vitro diagnostics (IVD) | |
Record changed: 2024-01-07 |
Advertisement
More documents for Thierry Bernard
- [1] Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo....
- [2] Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo....
- [3] Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD....
- [4] Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top